LINCOLN Share Price Target 2050

CAGR-based price projection for Lincoln Pharmaceuticals Limited (LINCOLN) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (0.3% CAGR)
Rs 621
2050 Target
Base Case (0.7% CAGR)
Rs 685
2050 Target
Bull Case (1.8% CAGR)
Rs 889
2050 Target

Current Market Snapshot

CMP: Rs 582.05
52W High: Rs 758.15
52W Low: Rs 572.15
1Y CAGR: 1.4%
3Y CAGR: 0.7%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 584 Rs 586 Rs 592
2028 Rs 585 Rs 590 Rs 603
2029 Rs 587 Rs 594 Rs 614
2030 Rs 588 Rs 598 Rs 625
2031 Rs 590 Rs 602 Rs 636
2032 Rs 592 Rs 606 Rs 647
2033 Rs 593 Rs 610 Rs 659
2034 Rs 595 Rs 615 Rs 670
2035 Rs 597 Rs 619 Rs 682
2036 Rs 598 Rs 623 Rs 695
2037 Rs 600 Rs 627 Rs 707
2038 Rs 601 Rs 632 Rs 720
2039 Rs 603 Rs 636 Rs 732
2040 Rs 605 Rs 640 Rs 745
2041 Rs 606 Rs 645 Rs 759
2042 Rs 608 Rs 649 Rs 772
2043 Rs 610 Rs 653 Rs 786
2044 Rs 611 Rs 658 Rs 800
2045 Rs 613 Rs 662 Rs 814
2046 Rs 615 Rs 667 Rs 829
2047 Rs 616 Rs 672 Rs 844
2048 Rs 618 Rs 676 Rs 859
2049 Rs 620 Rs 681 Rs 874
2050 Rs 621 Rs 685 Rs 889

Other LINCOLN Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the LINCOLN share price target for 2050?

Based on historical growth analysis, the LINCOLN share price target for 2050 ranges from Rs 621 (conservative) to Rs 685 (base case) to Rs 889 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of LINCOLN?

The current market price of LINCOLN (Lincoln Pharmaceuticals Limited) is Rs 582.05. The 52-week high is Rs 758.15 and 52-week low is Rs 572.15.

Is LINCOLN a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for LINCOLN price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 0.3% CAGR), Base (0.7% CAGR), and Bull (optimistic at 1.8% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.